Suvretta Capital Management, Llc - Dec 23, 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director, 10%+ Owner
Signature
Suvretta Capital Management, LLC; By: /s/Andrew Nathanson , General Counsel & Chief Compliance Officer
Stock symbol
BNTC
Transactions as of
Dec 23, 2024
Transactions value $
$527,174
Form type
4
Date filed
12/26/2024, 04:28 PM
Previous filing
Dec 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNTC Common stock, par value $0.0001 per share Purchase $267K +24.4K +0.31% $10.98 7.98M Dec 23, 2024 See footnotes F1, F2
transaction BNTC Common stock, par value $0.0001 per share Purchase $34.5K +3.14K +0.33% $10.98 958K Dec 23, 2024 See footnotes F1, F3
transaction BNTC Common stock, par value $0.0001 per share Purchase $199K +17.7K +0.22% $11.25 8M Dec 24, 2024 See footnotes F1, F4
transaction BNTC Common stock, par value $0.0001 per share Purchase $25.7K +2.29K +0.24% $11.25 961K Dec 24, 2024 See footnotes F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Notes are included on Exhibit 99.1.
F2 Notes are included on Exhibit 99.1.
F3 Notes are included on Exhibit 99.1.
F4 Notes are included on Exhibit 99.1.
F5 Notes are included on Exhibit 99.1.

Remarks:

Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature